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Foxp3+ regulatory T (Treg) cells limit pathogenic
immune responses to self-antigens and foreign anti-
gens. An essential role for microRNA (miRNA) in the
maintenance and function of Treg cells, revealed by
theTregcell-specificDicer ablation, raisedaquestion
as to a specific miRNA contribution. We found that
Foxp3 controlled the elevated miR155 expression
required formaintaining Treg cell proliferative activity
and numbers under nonlymphopenic conditions.
Moreover, miR155 deficiency in Treg cells resulted
in increased suppressor of cytokine signaling 1
(SOCS1) expression accompanied by impaired acti-
vation of signal transducer and activator of transcrip-
tion 5 (STAT5) transcription factor in response to
limiting amounts of interleukin-2.Our studies suggest
that Foxp3-dependent regulation of miR155 main-
tains competitive fitness of Treg cells by targeting
SOCS1, and they provide experimental support for
a proposed role for miRNAs in ensuring the robust-
ness of cellular phenotypes.
INTRODUCTION
A class of small noncoding RNA known as microRNA (miRNA)
has been implicated in the regulation of gene expression essen-
tial for organ development, cellular differentiation, homeostasis,
and functioning through target messenger RNA (mRNA) degra-
dation or translational control (Bartel, 2004). An important role
for the miRNA pathway in the immune system was revealed in
studies employing the T cell-specific deletion of a conditional
allele of Dicer1, encoding an RNase III enzyme critical for gener-
ation of mature miRNAs (Cobb et al., 2006; Cobb et al., 2005;
Muljo et al., 2005). Dicer-deficient T cells exhibit decreased
proliferative potential and increased apoptosis in response to
activation. Moreover, the Dicer-dependent miRNA pathway
influences effector CD4+ T cell differentiation (Cobb et al.,80 Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc.2005; Muljo et al., 2005). Recent studies have begun to explore
a role for individual miRNAs in lymphocyte biology. For example,
in B cells, miR150 has been shown to profoundly affect early
B cell differentiation and mature B cell responses by targeting
the transcription factor c-Myb (Xiao et al., 2007), whereas the
miR17–92 cluster can limit apoptosis through downregulation
of the proapoptotic protein Bim (Koralov et al., 2008; Ventura
et al., 2008; Xiao et al., 2008). In T cells, miR181a was shown
to influence thymic selection by modulating the sensitivity of
T cell receptor (TCR) signaling through downregulation of several
phosphatases involved in the attenuation of signal transduction
downstream of the TCR (Li et al., 2007).
Foxp3+ Treg cells play a pivotal role in maintaining immunolog-
ical tolerance. Ablation of these cells in healthy adult mice results
in a systemic autoimmune hyperproliferative syndrome, which
ultimately leads to death within 3 weeks (Kim et al., 2007). Disrup-
tion of the Dicer-dependent miRNA pathway at the double-
positive (DP) stage of thymocyte development upon deletion of
a conditional Dicer1 allele resulted in a 50%–70% reduction in
frequency of Foxp3+ Treg cells, suggesting a role for miRNA-
mediated gene regulation in Treg cell differentiation (Cobb et al.,
2006). Moreover, miRNAs are important for the elaboration of
Tregcell suppressor functionbecausemiRNAdepletion restricted
to the Foxp3+ Treg cell lineage caused fatal autoimmune disease,
identical to that observed in Foxp3-deficient mice lacking Treg
cells (Liston et al., 2008). In addition, in healthy mice cohabited
by Dicer-deficient and Dicer-sufficient Treg cells, the former
exhibit markedly diminished proliferative response and increased
apoptosis. Although a central role for theDicer-dependentmiRNA
pathway in various aspects of Treg cell biologywasmadeobvious
by thesegenetic studies, an understanding of the role of individual
miRNAs in this context is lacking. Previous studies identified a set
of miRNAs differentially expressed in Treg and ‘‘non-Treg’’ CD4+
T cells (Cobb et al., 2006). Among them,miR155, amiRNA largely
restricted tohematopoietic cells, isof aparticular interestbecause
Foxp3 binds to an intron within the DNA sequence encoding the
miR155 precursor mRNA, Bic (Marson et al., 2007; Zheng et al.,
2007). High miR155 expression in B cell malignancies in humans,
including Hodgkin’s and Burkitt lymphomas, implicated this
miRNA in hematopoietic cancers (Eis et al., 2005; Metzler et al.,
Immunity
miR155 Regulation of Treg Cell Homeostasis2004; van den Berg et al., 2003). As a corollary to these clinical
observations, B cell-restricted expression of a miR155 transgene
in mice led to preleukemic proliferation of B lineage cells, which
progressed to a severe B cell malignancy (Costinean et al.,
2006). Recent gene-targeting studies have further demonstrated
a broad role for miR155 in cells of the immune system. Depletion
of miR155 resulted in diminished germinal-center responses as
well as impaired B cell memory formation (Thai et al., 2007; Vigor-
ito et al., 2007). Moreover, miR155-deficient dendritic cells (DCs)
failed to induce efficient T cell activation in response to an antigen,
whereasactivatedmiR155-deficient Tcellswere impaired in inter-
leukin-2 (IL-2) production and displayed skewed differentiation
toward T helper 2 (Th2) cell lineage. The observed increase in
Th2 cell cytokine production was potentially due to an increased
Th2 cell transcription factor c-Maf, which was shown to serve as
a miR155 target (Rodriguez et al., 2007).
The central role Foxp3 plays in establishing the Treg cell
lineageand thepotential link betweenFoxp3andmiR155expres-
sion (Gavin et al., 2007; Marson et al., 2007; Zheng et al., 2007)
suggested that miR155 could be involved in regulating Treg cell
differentiation, maintenance, or function. Indeed, we found that
a high amount of miR155 in Treg cells required continuous
Foxp3 expression. Although a loss of miR155 did not apparently
change the sensitivity of Treg cells to induced apoptosis and did
not markedly impair Treg cell suppressor function, it resulted in
diminished Treg cell numbers and negatively impacted Treg cell
proliferative potential in a cell-autonomous fashion. Our results
suggest that during thymic differentiation, upregulation of Foxp3
drives high expression of miR155, which in turn promotes the
competitive fitness and proliferative potential of Treg cells by
inducingsuppressorof cytokinesignaling1 (SOCS1)downregula-
tion. These results demonstrate that a strategy employed by
Foxp3 to control Treg cell biology through fixing expression of
a number of molecules transiently expressed in conventional
T cells upon their activation extends to a specific microRNA.
RESULTS
Foxp3 Regulates miR155 Expression in Treg Cells
Previous studies showed increasedmiR155expression inperiph-
eral Foxp3-expressingTreg cells and in activated, but not resting,
‘‘non-regulatory’’ T cells and B cells (Cobb et al., 2006; Thai et al.,
2007). We sought to examine whether upregulation of Foxp3
during thymocyte differentiation coincides with upregulation of
miR155. We have previously shown that the bulk of Foxp3+ cells
are foundwithin the CD4+ single-positive (SP) andCD4+CD8+ DP
thymocyte subsets (Fontenot et al., 2005). Therefore, we exam-
inedmiR155expression inFoxp3+andFoxp3SPandDP thymo-
cyte subsets. Like in peripheral Treg cells (Figure S1 available
online), the miR155 expression in Foxp3+ CD4 SP thymocytes
was approximately 20-fold higher than that in the Foxp3 cell
population (Figures 1A and 1B). Furthermore, Foxp3+ DP thymo-
cytes also expressed an amount of miR155 approximately 8-fold
higher than that of their Foxp3 counterparts. These results sug-
gested that upregulation of Foxp3 during thymic differentiation of
Treg cells is accompanied by increased miR155 expression that
is sustained in peripheral Treg cells.
In agreement with this idea, studies from our lab and others
have demonstrated that Foxp3 binds to an intron within theDNA sequence encoding Bic, the precursor transcript of
miR155 (Marson et al., 2007; Zheng et al., 2007). These results
suggest that Foxp3 might directly control the high miR155
expression in Treg cells. Indeed, although forced expression of
Foxp3 in peripheral CD4+CD25 T cells resulted in miR155
Figure 1. High Amounts of miR155 Expression in Treg Cells Are
Driven by Foxp3
(A and B) Foxp3+ and Foxp3 DP and CD4 SP thymocyte subsets were
isolated, and Foxp3 (A) and miR155 (B) amounts were assessed by real-time
PCR. Data are representative of two independent experiments. Graphs
show mean ± standard deviation (SD).
(C) Diminished amounts of miR155 in Treg cells upon Foxp3 knockdown with
a Foxp3-specific shRNA. Foxp3 shRNA and the corresponding scrambled
shRNA (control) were expressed in Treg cells with a retroviral vector equipped
with a GFP reporter.
(D and E) GFP+ cells were sorted, and the expression of Foxp3 and miR155
were measured by real-time PCR analysis 3 days after retroviral infection.
Graphs show mean ± SD. The data represent two independent experiments.Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc. 81
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miR155 Regulation of Treg Cell HomeostasisFigure 2. Reduced Thymic and Peripheral Treg Cell Subsets in the Absence of miR155
(A) Flow-cytometric analysis of Foxp3+Treg cell subsets in 6- to 8-week-old miR155-deficient mice and wild-type littermates. The proportions (%) of different
thymocyte subsets and of Foxp3+ cells within in CD4 SP thymocyte and CD4+ splenic T cell subsets are shown.
(B–D) Cellularity of the thymus and spleen and the proportion and absolute numbers of thymic and splenic Foxp3+ and Foxp3CD4+ T cells in miR155-deficient
and miR155-sufficient mice are shown. Each symbol represents an individual mouse, and the bar represents the mean.upregulation (Cobb et al., 2006), disruption of Foxp3 protein
expression upon insertion of the GFP coding sequence into the
Foxp3 locus resulted in the loss of miR155 expression (Gavin
et al., 2007; Zheng et al., 2007). To establish a role for Foxp3 in
sustained miR155 expression in Treg cells, we performed
Foxp3 knockdown in primary Treg cells upon transduction with
Foxp3 short hairpin RNA (shRNA)-expressing retroviral vectors.
Within 3 days after retroviral infection, Foxp3 expression was
greatly diminished at both the protein and mRNA levels in GFP+
Treg cells transduced with retroviral vectors expressing two
different Foxp3-specific shRNAs as compared to that in GFP+
Treg cells transducedwith a control vector containing scrambled
shRNA sequences (Figures 1C and 1D). Similarly, miR155
expression as well as the amount of its precursor transcript
(Bic) were diminished upon a decrease in Foxp3 expression in82 Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc.sorted GFP+ Treg cells (Figure 1E and data not shown). These
results indicated that continuous Foxp3 expression is indispens-
able for themaintenance of high amounts ofmiR155 in Treg cells.
miR155 Deficiency Results in a Reduction
of Treg Cell Numbers
To investigate the role of miR155 in Treg cell biology, we exam-
ined thymic and peripheral Foxp3+ cell subsets in recently
described miR155-deficient mice (Thai et al., 2007). Those
mice remained healthy without detectable immune-mediated
pathology. Although we did not observe substantial changes in
T cell activation status or numbers, miR155-deficient mice
displayed a marked reduction in the proportion and absolute
numbers of Foxp3+ cells, both in the thymus and in the periphery
(Figures 2A–2D).
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production by T cells and the antigen-presenting and costimula-
tory capacity of DCs were both impaired in the absence of
miR155 (Rodriguez et al., 2007). Because IL-2 plays an important
role in maintaining Treg cell homeostasis, it was possible that the
numerical reduction in Treg cells in miR155-deficient mice was
due to the limited supply of IL-2 by non-Treg cells. Moreover,
other cell-extrinsic factors, such as an impaired DC function,
might also contribute to the impaired Treg cell homeostasis
observed in the miR155-deficient mice.
To discriminate between the cell-intrinsic and cell-extrinsic
effects of miR155 deficiency in the Treg cell lineage, we trans-
ferred bonemarrow (BM) frommiR155-deficient ormiR155-suffi-
cient littermatesmixedwith BM fromLy5.1+ B6mice at a 1:1 ratio
into Rag2-deficient recipients. The presence of miR155-
sufficient and miR155-deficient Foxp3+ T cells in the peripheral
blood of the resulting chimeras was assessed at different time
points after BM reconstitution (Figure 3A). Unexpectedly, we
did not detect a marked difference in the frequencies of
miR155-deficient and miR155-sufficient Treg cells 40 days after
BM transfer (Figures 3B and 3C). However, 100 days after BM
transfer, the proportion of Foxp3+ Treg cells within the miR155-
deficient CD4+ T cell population decreased to approximately
a third of that in themiR155-sufficient CD4+ T cell subset (Figures
3B and 3C). Further analysis showed a comparable 50%–70%
reduction in the frequencies of Foxp3+ Treg cells within the
miR155-deficient thymic and peripheral CD4+ T cell subsets
compared to those in the corresponding control subsets in the
mixed chimeras 4 months after BM transfer (Figures 3D and
3E). The decrease in the proportion of the miR155-deficient
Treg cell subset in themixed BM chimeras together with a similar
numerical decrease of the Treg cell subset in unmanipulated
miR155 mice suggested that miR155 deficiency affects the
Treg cell homeostasis in a cell-autonomous manner. Interest-
ingly, despite the reduced numbers, miR155 was dispensable
for Treg cell suppression function. miR155-deficient Treg cells
isolated from BM chimeras or unmanipulated mice displayed
only moderately diminished in vitro suppression activity (Fig-
ure S2A). Furthermore, miR155-deficient Treg cells were able to
maintain immunological tolerance and prevent autoimmune
disease in a miR155-sufficient environment, whereas the control
group of BM chimeras became moribund and succumbed to
terminal disease within 10 days of complete Treg cell ablation
(Figures S2 and S3 and data not shown) (Kim et al., 2007).
Diminished Proliferative Potential
of miR155-Deficient Treg Cells
Recent studies of T cells deprived of miRNAs upon ablation of
a conditional Dicer1 allele showed that the Foxp3+ Treg cell
subset was reduced to a degree comparable to that in
miR155-deficient mice and that transforming growth factor
b (TGF-b)-dependent Foxp3 induction in peripheral Foxp3
T cells was diminished (Cobb et al., 2006). On the basis of these
findings, the miRNA pathway was proposed to be important for
Treg cell lineage commitment (Cobb et al., 2006). However, our
observation of normal thymic development and the presence of
comparable numbers of thymic and peripheral miR155-defi-
cient and miR155-sufficient Foxp3+ Treg cells in chimeric
mice 6–8 weeks after mixed BM reconstitution (Figure 3 andFigure S4) as well as equally efficient TGF-b-dependent
induction of Foxp3 in peripheral non-Treg cells (Figure S5)
largely discounted a cell-intrinsic role for miR155 in Treg cell
differentiation.
Previous studies implicated miR155 in the control of both
cellular proliferation and death. Overexpression of miR155 re-
sulted in the upregulation of more than 200 genes related to
the regulation of the cell cycle (Costinean et al., 2006) and the
inhibition of apoptosis through a blockade of caspase-3 activity
(Ovcharenko et al., 2007). The latter was proposed to be associ-
ated with downregulation of proapoptotic molecules such as
TP53BP1 (Gironella et al., 2007). Therefore, it was possible that
high amounts of miR155 expression in Treg cells were required
for their resistance to apoptosis, proliferative capacity, or both.
To address these issues, we first examined whether the loss of
miR155 led to an increase in apoptosis in Treg cells stimulated
in vitro by CD3 crosslinking. We found very few apoptotic
Foxp3+ Treg cells in ex vivo-isolated miR155-deficient or
miR155-sufficient CD25+ Treg cell populations (Figure 4).
Furthermore, we observed comparable progressive increases
in apoptotic cell numbers of either mutant or control Treg cells
upon in vitro CD3 crosslinking in the presence or absence of
IL-2 as well as Fas crosslinking (Figure 4 and Figure S6).
Next, we examinedwhethermiR155 is required formaintaining
the Treg cell proliferative potential through enumeration of
Ki67-expressing cycling cells. As shown in Figures 5A–5D, we
found a decreased proportion of Ki67+ cells within thymic and
peripheral miR155-deficient Ly5.1Foxp3+ Treg cell subsets
compared to that in miR155-sufficient controls (1.32% versus
4.02% in the thymus and 5.68% versus 10.30% in the spleen).
In contrast, the proportion of cycling Ki67+ cells was reduced
only within the peripheral, but not thymic, miR155-deficient
Foxp3 CD4+ T cell subset, in comparison to that in the wild-
type miR155-sufficient cell subsets (10.43% versus 9.70% in
the thymus and 1.56%versus 4.38% in the spleen). In agreement
with these results, we found comparable numbers of miR155-
sufficient and miR155-deficient Foxp3 cells at all thymic devel-
opmental stages inmixed BMchimeras (Figure S7A). In contrast,
the splenicmiR155-deficient CD4+ and CD8+ T cell subsets were
markedly decreased in comparison to their wild-type counter-
parts, whereas the numbers of B cells and DCs were unaffected
bymiR155 deficiency (Figure S7B). These data suggest that Treg
cell homeostasis is impaired in the absence of miR155. In addi-
tion, the diminished proliferative activity of peripheral miR155-
deficient Foxp3 T cells indicates some involvement of miR155
in non-Treg cell homeostasis in the periphery (Figure S8).
miR155 Maintains Competitive Fitness
of Treg Cells
The reduction in the proportion and the overall numbers of
miR155-deficient Treg cells in chimeric mice observed only
relatively late after reconstitution with miR155-deficient and
miR155-sufficient BM suggested that miR155 is required to
maintain proliferative fitness of Treg cells in ‘‘lymphoreplete’’
mice, in which cells compete for limiting growth factors, but
not in lymphopenic mice, in which competition for growth factors
is lacking. To test this notion, we examined the proportion of
Ki67+ Treg cells at different time points after BM reconstitution.
Indeed, we observed the reduction in the proportion of cyclingImmunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc. 83
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miR155 Regulation of Treg Cell HomeostasisFigure 3. miR155-Deficient Treg Cells Exhibit Impaired Homeostais
(A) Schematic of generation of mixed BM chimeric mice.
(B) Treg cell frequencies within each donor-derived population of peripheral-blood lymphocytes at various time points after BM transfer.
(C) The ratios of Ly5.1Foxp3+ (Mirn155/ or WT littermates) and Ly5.1+Foxp3+ cells were plotted over time.
(D) Treg cell frequencies within each donor-derived T cell population from both the thymus and spleen 120 days after BM transfer.
(E) The ratio of thymic and splenic Ly5.1Foxp3+ and Ly5.1+Foxp3+ cells 120 days after BM transfer. The data in (C) and (E) represent three independent
experiments. Each symbol represents an individual mouse, and the bar represents the mean.Ki67+ miR155-deficient Treg cells only at a later time point after
BM reconstitution (Figure 5E). To further prove that the dimin-
ished cycling ofmiR155-deficient Treg cells is due to their inferior
ability to compete with miR155-sufficient Treg cells, not due to
an irreversible loss of their proliferative potential, we transferred
amiR155-deficient T cell population, containing few cycling cells84 Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc.4 months post BM transfer, into Rag2-deficient recipients
(Figure S9A). Upon reintroduction into a lymphopenic environ-
ment, both Foxp3+ Treg cells and Foxp3 non-Treg cells prolif-
erated as robustly as their miR155-sufficient counterparts
(Figures 5F and 5G). Moreover, the total numbers of miR155-
deficient and miR155-sufficient Treg cells recovered 2 weeks
Immunity
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input Treg cell population 120 days after BM transfer (Figure S9).
Thus, miR155 confers proliferative fitness of Treg cells in a full
lymphoid compartment.
Attenuated IL-2 Signaling in miR155-Deficient
Treg Cells
IL-2 has long been known for its indispensable role in Treg cell
homeostasis (Bayer et al., 2007). It was therefore possible that
diminished Treg cell proliferative activity in the absence of
miR155 was due to impaired signaling in response to limiting
amounts of IL-2. Indeed, we found comparable signal transducer
and activator of transcription 5 (STAT5) phosphorylation in
miR155-deficient and miR155-sufficient Treg cells in response
to high amounts of IL-2 (Figure 6A). In response to a lower
concentration of IL-2, however, markedly reduced STAT5
phosphorylation was observed in miR155-deficient Treg cells
as compared to that in their miR155-sufficient counterparts
(Figure 6A). This finding was fully consistent with the observation
that miR155 confers Treg cell proliferative fitness only in the
competitive environment of lymphoreplete mice where IL-2 is
likely limiting.
Figure 4. miR155 Deficiency Does Not Affect Treg Cell Susceptibility
to Activation-Induced Cell Death
Sorted CD4+CD25 (Teff) and CD4+CD25hi (Treg) cells frommiR155- deficient
mice or littermate controlswere cultured in vitrowith plate-boundCD3 (1mg/ml)
antibodies. Apoptotic cells were labeled with the active caspase-3 probe
FITC-VAD-FMK at indicated time points and enumerated with flow-cytometric
analysis. Data are representative of two independent experiments (n = 4).miR155 Maintains Treg Cell Homeostasis by Limiting
SOCS1 Protein Expression
To gain an insight into the mechanistic aspect of how miR155
influences the IL-2 signaling pathway, we conducted a computa-
tional analysis of putative miR155 targets with the PicTar algo-
rithm (Krek et al., 2005). Among the predicted miR155 targets,
SOCS1 was the only protein with a known inhibitory role in the
IL-2 signaling pathway leading to reduced STAT5 phosphoryla-
tion (Sporri et al., 2001). Previous studies employing microarray
analysis revealed increased amounts of the SOCS1 transcript
in Treg cells in comparison to that in non-Treg cells (Gavin
et al., 2002; McHugh et al., 2002). In agreement with these earlier
results,wedetectedelevatedSOCS1mRNAamounts inmiR155-
sufficient, but also in miR155-deficient, Treg cells (Figure 6B).
However, despite high amounts of the SOCS1 transcript, the
SOCS1protein amountswere low inmiR155-sufficient Tregcells,
whereas miR155-deficient Treg cells exhibited an approximately
5-fold increase in the amounts of SOCS1 (Figure 6C). Moreover,
the elevated SOCS1 protein level in miR155-deficient Treg cells
was diminished when miR155 was reintroduced (Figure S10). In
contrast to Treg cells, only a modest (less than 2-fold) increase
of SOCS1 protein expression was observed in non-Treg cells
lacking Foxp3 protein expression in the absence of miR155
(Figure 6C). To further examine whether miR155 directly regu-
lates SOCS1, we employed a luciferase reporter construct
containing the SOCS1 30 untranslated region (UTR) with an intact
ormutatedmiR155 binding sequence (Figure 6D). These reporter
constructs were cotransfected with miR155 or a control miRNA,
miR150, into HEK293T cells. Cotransfection of the intact SOCS1
30 UTR with miR155 resulted in an appreciable repression of the
reporter activity, whereas mutation of the miR155 seed-binding
sequence abolished this repression (Figure 6E). In the control,
miR150 did not affect expression of the luciferase reporter with
the intact or mutant SOCS1 30 UTR (Figure 6E). Together, these
results suggest that SOCS1 protein expression is directly
controlled by miR155.
Next, we sought to examine whether increased SOCS1
expression in miR155-sufficient mice can result in a decrease in
Treg cell numbers. To address this question,we assessedpoten-
tial changes in Foxp3+ subset size in mice expressing SOCS1
transgene under a T cell-specific lck promotor (SOCS1 Tg). As
described previously, SOCS1 Tg expression did not lead to
detectable abnormalities in thymic differentiation (Hanada et al.,
2003). However, it was also demonstrated that another strain of
mice with higher amounts of SOCS1 Tg expression developed
inflammatory pathology, i.e., spontaneous colitis (Inagaki-Ohara
et al., 2006). Therefore, to exclude potential secondary effects
of SOCS1 overexpression on peripheral Treg cell subsets, we
examined Foxp3+ thymocytes in SOCS1 Tg mice and wild-type
littermates. As shown in Figures 6F and 6G, SOCS1 Tg mice
exhibited a reduced proportion and absolute number of Foxp3+
thymocytes analogous to miR155-deficient mice. Complement-
ing these results, we found an increased proportion and
increased absolute numbers of Foxp3+ thymocytes upon
lck-Cre-driven deletion of a conditional Socs1 allele in the T cell
lineage (SOCS1 cKO) (Figures 6F and 6G and Figure S11).
Thus, these experiments strongly suggest that Foxp3-driven
miR155 expression defines the size of the Foxp3+ Treg cell
subset by conferring competitive fitness to Treg cells, at leastImmunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc. 85
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regulator of IL-2 receptor (IL-2R) signaling.
DISCUSSION
The transcription factor Foxp3 orchestrates a specific transcrip-
tional program that is required for the establishment and mainte-
nance of the Treg cell lineage and Treg cell function. Previous
studies have identified a set of Foxp3 target genes essential
for Treg cell homeostasis and function. Among these genes,
the Mirn155 gene, which encodes miR155, is of particular
interest (Marson et al., 2007; Zheng et al., 2007). The experi-
ments presented here suggest that high amounts of miR155
are induced by Foxp3 in thymic Treg cell precursors and
maintained in a Foxp3-dependent manner in peripheral Treg
cells. We further found that miR155-deficient mice exhibit
markedly diminished Foxp3+ cell subsets in the thymus and
periphery, yet they did not manifest enhanced activation of
T cells and antigen-presenting cells or clinical signs of autoim-
mune disease.
A number of factors such as defective microenvironment,
impaired lineage commitment, or increased Treg cell death
could potentially account for the reduced Treg cell numbers in
miR155-deficient mice. Our studies revealed a cell-intrinsic
role for miR155 expression in Foxp3+ Treg cell long-termmainte-
nance, but not in thymic or peripheral differentiation. Further
experiments suggested the presence or absence of miR155 on
its own does not automatically alter the sensitivity of Treg cells
to induced apoptosis. However, given that miR155 deficiency
impairs IL-2 signaling and that a role of IL-2 signaling in the
survival of Treg cells is well established, miR155 deficiency in
Treg cells very likely leads to reduced survival in vivo in the pres-
ence of limited amounts of IL-2. In addition, we observed
a marked decrease in the proliferative activity of miR155-defi-
cient Treg cells both in the thymus and in the periphery in
comparison to that of their miR155-sufficient counterparts.
Thus, the diminished size of the miR155-deficient Treg cell
subset is most likely to be due to a combination of diminished
thymic output and impaired peripheral homeostasis. Our most
intriguing finding was that the reduction in the proportion of
cycling Ki67+ cells and in the overall numbers of miR155-defi-
cient Treg cells was detectable in chimeric mice only late after
reconstitution with miR155-deficient and miR155-sufficient
BM. Furthermore, when those cells were reintroduced into
a noncompetitive lymphopenic environment, they were able toproliferate at a level comparable to that of their miR155-sufficient
counterparts. These results suggested that miR155 is required
for competitive fitness of Treg cells, whereas it is dispensable
in noncompetitive lymphopenic settings.
It is well established that IL-2 is required for thymic and periph-
eral Treg cell maintenance (Bayer et al., 2007; Setoguchi et al.,
2005), making IL-2R signaling a likely target of miR155-mediated
regulation. Although we cannot formally exclude the possible
contribution of other pathways targeted by miR155 to the
observed phenomenon, inferior STAT5 phosphorylation in
miR155-deficient Treg cells upon IL-2 stimulation provided
a very likely explanation for the reduced number of Treg cells
observed in miR155-deficient mice. Moreover, the observation
that attenuated IL-2 signaling leading to decreased STAT5 acti-
vation can be compensated by high concentrations of IL-2 stim-
ulation further supports the role of miR155 in maintaining Treg
cell competitive fitness.
Importantly, our study provided a mechanistic insight into the
role of miR155 in controlling the IL-2 signaling pathway by
demonstrating that SOCS1, a negative regulator of the IL-2
signaling cascade, is translationally inhibited by miR155. These
results are consistent with previous reports that overexpression
of the SOCS1 protein in T cells results in impaired IL-2 signaling,
whereas T cells from SOCS-1-deficient mice are hypersensitive
to IL-2 stimulation (Cornish et al., 2003; Sporri et al., 2001).
Further support for ourmodel of themiR155-mediated regulation
of the Treg cell subset size is provided by our observation of
a comparable reduction in Treg cell numbers upon SOCS1 trans-
gene expression. Thus, our study suggests that in addition to
driving increased expression of high-affinity IL-2R (Marson
et al., 2007; Zheng et al., 2007), Foxp3 drives elevated expres-
sion of miR155, leading to translational downregulation of the
SOCS1 protein, which in turn leads to a heightened sensitivity
of Treg cells to IL-2 stimulation. In the absence of miR155,
increased amounts of SOCS1 negatively impact IL-2-dependent
Treg cell homeostasis by increasing the threshold of IL-2R
signaling.
It is noteworthy that a notable, albeit less pronounced, effect
of miR155 deficiency extends to the homeostasis of peripheral
Foxp3 T cells, which are known to upregulate miR155 upon
activation (Thai et al., 2007). Therefore, the questions have
been raised as to how different is miR155-mediated SOCS1
regulation in non-Treg cells and in Treg cells. As demonstrated
by previous studies, Foxp3 fixes and enhances expression
of a number of genes only transiently expressed in activatedFigure 5. Diminished Proliferative Activity of Treg Cells in the Absence of miR155 in the Competitive Environment of Lymphoreplete, but Not
Lymphopenic, Mice
(A) Expression of Ki67 in Ly5.1+ (C57/B6) or Ly5.1 (Mirn155/ orWT littermates) SP thymocytes 120 days after BM reconstitution. The frequency of Ki67+ cells in
either Foxp3+ or Foxp3 population is indicated.
(B) The ratios of Ly5.1Ki67+ (Mirn155/ or WT littermates) and Ly5.1+Ki67+ cells within either the Foxp3+ or Foxp3 CD4 SP thymocyte subset.
(C) Expression of Ki67 in Ly5.1+ or Ly5.1 splenic CD4+ T cells. The frequency of Ki67+ cells within either Foxp3+ or Foxp3 CD4+ T cell subsets is indicated.
(D) The ratios of Ly5.1Ki67+ and Ly5.1+Ki67+ cells within Foxp3+ and Foxp3 splenic CD4+ T cell subsets. Data are representative of two independent
experiments.
(E) Expression of Ki67 within each donor-derived population of peripheral-blood lymphocytes at various time points after BM transfer. The ratios of
Ki67+Ly5.1Foxp3+ (Mirn155/ or WT littermates) and Ki67+Ly5.1+Foxp3+ cells were analyzed over time.
(F) Expression of Ki67 within Foxp3CD4+ and Foxp3+CD4+ T cell subsets from Mirn155/ (black line) or WT littermates (tinted) 14 days after transfer was
assessed by flow-cytometric analysis.
(G) The frequencies of Ki67+ cells in either miR155-sufficient or miR155-deficient populations were plotted. Data are representative of two independent
experiments. Each symbol represents an individual mouse, and the bar represents the mean.Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc. 87
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miR155 Regulation of Treg Cell HomeostasisFigure 6. miR155 Modulates Sensitivity of Treg Cells to IL-2 by Targeting SOCS1
(A) Flow-cytometric analysis of Stat5 phosphorylation in miR155-deficient and miR155-sufficient Treg cells induced upon stimulation with IL-2 at the indicated
concentrations.
(B) Expression of the SOCS1 transcript wasmeasured by real-time PCR. TN: naive CD4
+CD25CD62Lhi cells; TE: non-Treg cells activated with anti-CD3 and anti-
CD28 for 48 hr; TR: CD4
+CD25+ cells.
(C) Immunoblot analysis of the SOCS1 protein expression. Densitometric SOCS1 expression values normalized on the basis of b-actin expression values are
indicated below the corresponding lanes, as is fold increase in normalized SOCS1 expression in the absence of miR155 in the indicated T cell subsets.
(D) Multiple species sequence alignment of the SOCS1 30 UTR including the predicted miR155 target site sequence (in bold). Mutation of the miR155 target site
sequence is shown below.
(E) 293T cells were cotransfectedwithWT ormutated SOCS1 30UTR andmiR155 and assessed for luciferase activity 24 hr after transfection. MiR150was used as
a control miRNA in these experiments.
(F and G) The proportion (F) and absolute numbers (G) of thymic Foxp3+ Treg cells in WT littermate control mice, SOCS1 transgenic (Tg) mice, and SOCS1 condi-
tional knockout (cKO)mice . The data shown in every panel are representative of two ormore independent experiments (n = 3–6); values represent themean ± SD,
*p < 0.005.non-Treg cells to benefit Treg cell homeostasis. In addition to
miR155, this group of genes includes CTLA4 and CD25. Consis-
tent with transient miR155 expression in non-Treg cells, miR155
deficiency also affected this cell subset, as suggested by the
reduction in miR155-deficient Foxp3 T cells in comparison to
miR155-sufficient counterparts in mixed chimeras late after
BM reconstitution. We also observed increased SOCS1 protein
levels in non-Treg cells in the absence of miR155. Therefore, it88 Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc.is possible that miR155-dependent SOCS1 regulation also
contributes to the homeostasis of non-Treg cells. However,
although in the absence of miR155 the bulk non-Treg cell popu-
lation exhibited increased SOCS1 levels, it never reached the
SOCS1 amounts in miR155-deficient Treg cells (2-fold versus
5-fold increase, respectively). Furthermore, in activated
T cells (T effector [Teff] cells), a modest increase in the SOCS1
amount in the absence of miR155 suggested a difference in
Immunity
miR155 Regulation of Treg Cell HomeostasisSOCS1 regulation between Treg and non-Treg cells. Although
low SOCS1 expression in Treg cells is controlled by miR155 at
a protein, but not mRNA, level (SOCS1 mRNA level remains
high in Treg cells regardless of the presence or absence of
miR155), the amount of SOCS1 in activated non-Treg cells is
regulated at both mRNA and protein levels. Finally, homeostasis
of Treg cells and homeostasis of non-Treg cells are different in
their reliance on different growth factors. Although IL-2 is essen-
tial for Treg cells, non-Treg cells are not solely dependent on IL-2
or IL-15 signaling. Thus, it is not surprising that Foxp3+ Treg cells
were affected by miR155 deficiency more profoundly and that
we consistently observed a reduced frequency of miR155-defi-
cient Treg cells within the total miR155-deficient T cell popula-
tion in both miR155 null mice or in mixed BM chimeras.
In addition to IL-2R, miR155-dependent SOCS1 regulation in
Treg cells could also impact signaling through other cytokine
receptors, e.g., IL-15R, and potentially noncytokine signaling
pathways, such as Toll-like receptors (TLRs) (Yoshimura et al.,
2007). Moreover, miR155-dependent SOCS1 regulation is also
probably applicable to other cell types, and it helps explain
some of the immune defects previously described in miR155-
deficient mice. For example, miR155-deficent DCs fail to effi-
ciently activate T cells, whereas miR155-deficient CD4+ T cells
exhibit increased Th2 cell polarization and produce high amounts
of Th2 cell cytokines (Rodriguez et al., 2007; Thai et al., 2007). In
this regard, it has been previously shown that SOCS1 negatively
regulates the antigen-presenting capacity of DCs (Evel-Kabler
et al., 2006). In T cells, the amount of SOCS1 affects the balance
between Th1 and Th2 cell differentiation. Higher amounts of
SOCS1 protein suppress IL-12 and IFN-g signaling, leading to
a Th1 cell differentiation blockade, while promoting Th2 cell
induction (Harada et al., 2007; Yoshimura et al., 2007).
In conclusion, miR155 is required for Treg cell homeostasis in
the presence of limiting amounts of IL-2, whereas it is dispens-
able in noncompetitive lymphopenic settings. Foxp3-dependent
upregulation and maintenance of high amounts of miR155 in
Treg cells maintains Treg cell homeostasis by targeting SOCS1
and by ensuring increased sensitivity of these cells to their prin-
cipal growth factor, IL-2. Unlike the pleiotropic effects of the bulk
miRNA depletion resulting from the Dicer ablation, the focused
effect of miR155 deficiency on Treg cells suggests that multiple
miRNAs affect distinct facets of Treg cell biology. Finally, our
studies provide experimental support for a proposed role for
miRNA-dependent gene regulation in ensuring robustness of
the cellular phenotypes (Hornstein and Shomron, 2006).
EXPERIMENTAL PROCEDURES
Mice
Mirn155/ (Thai et al., 2007), Foxp3DTR (Kim et al., 2007), SOCS1 Tg (Hanada
et al., 2003), and SOCS1 cKO (Tanaka et al., 2008) mice were described
elsewhere. Experimental mice were age matched and housed under specific
pathogen-free conditions. All mice were used in accordance with guidelines
from the University of Washington Institutional Animal Care Committee.
shRNA Knockdown and Quantitative PCR Analysis
For Foxp3 shRNA knockdown, shRNA sequences were designed with
commonly used algorithms. The sequences targeted by two Foxp3-specific
shRNAs are as follows: A: CACTATCACACATAGGTGT; B: CAGACACCATCC
TAATATTT. These sequences were cloned into a retroviral vector pRNAT-
H1.1-Retro, packaged with Phoenix-E cells, and used for transduction ofMACS-purified CD4+CD25+ cells stimulated overnight with plate-bound anti-
CD3 (1 mg/ml), anti-CD28 (1 mg/ml), and IL-2 (200 U/ml). Cells were maintained
in IL-2 for 60–72 hr posttransduction, followed by analysis of Foxp3 expression
by flow cytometry or quantitative PCR.
For quantitative PCR (qPCR) analysis, total RNA (including microRNA) was
prepared from FACS-purified cells previously treated with Foxp3-specific or
control shRNA with Trizol (Invitrogen). First-strand complementary DNA was
synthesized with the NCode miRNA First-Strand cDNA Kit (Invitrogen).
Amounts of miRNA were measured by qPCR according to the manufacturer’s
instructions. Ubiquitously expressed U6 small nuclear RNA was used for
normalization.
Generation of BM Chimeras
Single suspensions of BM extracted from femurs and tibias were depleted of
T cells with Thy1 antibody-coated magnetic beads. 3–5 3 106 T cell-depleted
BM cells were transferred individually or at a 1:1 ratio into lethally irradiated
(950 rads) Rag2/ recipients. BM engraftment was examined by flow-
cytometric analysis of peripheral-blood lymphocytes at indicated times.
Chimeric mice were euthanized and analyzed 120 days after BM transfer.
Ly5.1CD4+CD25CD62Lhi Teff cells and Ly5.1CD4+CD25hi Treg cells orig-
inating from mirn155/ or mirn155+/+ BM were sorted and used in functional
assays described below.
In Vitro Apoptosis Assays
For apoptosis study, 1 3 105 CD4+CD25 and CD4+CD25hi T cells isolated
from mirn155/and mirn155+/+ mice were cultured in 96-well plates with
1 mg/ml CD3 (2C11) antibody at 37C for the indicated time. FITC-VAD-FMK
(Promega) was used for measuring caspase-3 activity according to the manu-
facturer’s instructions. Cells were harvested, and the presence of apoptotic
cells was assessed by flow-cytometric analysis.
Flow-Cytometric Analysis
Cell were stained with CD4 (clone L3T4), CD8 (clone 53-6.7), CD25 (clone
PC61), and Ly5.1 (clone A20) antibodies, followed by intracellular staining
with Foxp3 (clone FJK-16 s, eBioscience), GFP and YFP (polyclonal rabbit,
Invitrogen), and Ki67 (polyclonal rabbit, BD Biosciences) antibodies and
subjected to flow-cytometric analysis with a FACS Canto flow cytometer
(Becton Dickinson). Fixation and permeabilization of cells were performed
with the reagents from the eBioscience Foxp3 staining kit.
For phospho-STAT5 staining, cells were stimulated for 20min with indicated
IL-2 concentrations in 37C. An equal volume of 3.2% formaldehyde in PBS
was added directly into the culture for fixation. After 15 min incubation at
room temperature, cells were harvested and washed twice with PBS, followed
by permeabilization with ice-cold 100% MtOH for 25 min on ice. Cells were
then washed twice and stained with the phospho-Stat5 antibody (clone 47,
BD Biosciences) and antibodies specific for other cell-surface molecules.
Luciferase Reporter Assay
HEK293T cells were cultured at 3.53 105 cells/well in 6-well plate 1 day prior to
transfection. psiCheck2 luciferase reporter plasmids (Promega) containing
either WT or mutated SOCS1 30 UTR and miR155-expressing or control
miR150-expressingpMDH-PGK-EGFPplasmids (Zhouetal.,2007)werecotrans-
fected into HEK293T cells with Fugene 6 transfection reagent (Roche). Cellswere
harvested 24 hr later, and luciferase activity was assessed with the Dual-Lucif-
erase Reporter Assay System (Promega) according to manufacturer’s protocol.
Immunoblot Analysis
Isolated Treg cells (5 3 105) were lysed with a chilled lysis buffer (50 mM Tris-
Hcl (pH 7.4), 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA,
1 mM PMSF, 1X Protease Inhibitor Cocktail). Cell debris was removed by
centrifugation at 14,000 rpm for 15min at 4C, and the supernatant was imme-
diately transferred to a fresh tube. Solubilized proteins were separated with
SDS-PAGE and transferred to a nitrocellulose membrane. SOCS1 and b-actin
(loading control) were visualized withmonoclonal antibodies ab62584 (Abcam)
and AC-74 (Sigma), correspondingly. Protein quantitation was performed with
NIH Image J software (http://rsb.info.nih.gov/ij/).Immunity 30, 80–91, January 16, 2009 ª2009 Elsevier Inc. 89
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